XML 84 R37.htm IDEA: XBRL DOCUMENT  v2.3.0.11
Stock Compensation Plans (Narrative) (Details) (USD $)
In Millions, except Share data, unless otherwise specified
3 Months Ended 6 Months Ended 3 Months Ended 6 Months Ended 3 Months Ended 6 Months Ended
Jun. 30, 2011
Jun. 30, 2010
Jun. 30, 2011
Jun. 30, 2010
Jun. 30, 2011
Settled Stock Appreciation Rights [Member]
Jun. 30, 2010
Settled Stock Appreciation Rights [Member]
Jun. 30, 2011
Settled Stock Appreciation Rights [Member]
Jun. 30, 2010
Settled Stock Appreciation Rights [Member]
Dec. 31, 2010
Settled Stock Appreciation Rights [Member]
Jun. 30, 2011
Director Restricted Stock Grants [Member]
Jun. 30, 2011
Director Restricted Stock Grants [Member]
Jun. 30, 2011
2006 Plan [Member]
Jun. 30, 2010
2006 Plan [Member]
Jun. 30, 2011
Amendment and Restatement of the 2006 Plan [Member]
Apr. 21, 2011
Amendment and Restatement of the 2006 Plan [Member]
Weighted average grant-date fair value of performance awards granted             $ 22.58 $ 14.51       $ 53.18 $ 33.65    
Number of awards granted 1,935,437   1,935,437                 624,400   781,500  
Number of share approved for issuance 4,300,000   4,300,000                 10,000,000   10,000,000  
Share based compensation, additional number of share approved for issuance                             5,000,000
Stock compensation expense $ 7.0 $ 3.5 $ 11.7 $ 5.5 $ 0.6 $ 0.6 $ 1.3 $ 1.3   $ 0.9          
Weighted average remaining contractual life of SSARs outstanding, in years             5                
Total compensation cost not yet recognized             6.0             52.5  
Weighted-average period for compensation cost expected to be recognized, in years             3             4  
Total fair value of SSARs vested     2.2                        
Number of shares not vested 448,194   448,194   824,635   824,635   798,197            
Total intrinsic value of outstanding SSARs 11.8   11.8                        
Total intrinsic value of exercisable SSARs     5.8                        
Total intrinsic value of SSARs exercised     3.4                        
Restricted stocks granted             150,000       16,560        
Restricted common stocks issued                     12,034        
Outstanding and exercisable options aggregate intrinsic value 0.5   0.5                        
The total intrinsic value of options exercised     0.2                        
Cash received from stock option exercises     $ 0.1                        
Outstanding and exercisable options weighted average remaining contractual life     1